In Depth
A real risk assessment is more than a list of worries. It works from the agent's actual context (what it does, how autonomously it acts, what data it touches, who relies on its output) and walks each plausible failure to its consequence. A hallucination in a recipe bot and a hallucination in a clinical summarizer are the same technical failure with wildly different stakes, and an assessment that doesn't capture that difference isn't doing its job.
This is the Map and Measure work in the NIST AI RMF. Map establishes context: intended use, the people affected, the domain's stakes. Measure quantifies: how often the failure occurs under test, how severe the outcome is, how confident you are in those numbers. The product is a prioritized picture of risk. Rather than treating every conceivable harm equally, it pushes the few that are both likely and severe to the front, where controls and budget should go.
An assessment is only as good as its inputs, which is why it pairs with testing. Asserting that an agent "rarely hallucinates" is a guess; red-teaming that produces a measured failure rate under adversarial prompts is evidence. The strongest assessments are grounded in observed behavior, not the team's optimism about their own system.
What It Looks Like
A vendor assessing an autonomous scheduling agent for a clinic maps its reach: it can read patient contact details, send messages, and book appointments with no human approval. The assessment flags two high-priority risks, an autonomous message containing PHI sent to the wrong recipient and a booking error that delays care, plus a handful of lower ones. That ranking changes the product: the team adds a confirmation step before any message goes out, which is exactly the kind of control that lowers real-world risk and the agent's cost to insure at the same time.
Why It Matters For AI Vendors
The assessment is the hinge between knowing your risk and managing it. Skip it and you're applying controls by gut feel, over-investing where it's cheap to feel safe and under-investing where the real exposure lives. Done well, it tells you where human review, guardrails, or narrower scope will buy the most safety per dollar. It's also the document a buyer's security team and an underwriter both want to see, because it shows you understand your own agent's failure surface rather than hoping it doesn't have one.